Previous microarray expression analyses have indicated autocrine human growth hormone (hGH) regulation of genes involved in the oxidative stress response. Expression analysis of antioxidant enzymes revealed that autocrine hGH increased both the mRNA and protein levels of catalase, superoxide dismutase 1 (SOD1), glutathione peroxidase and glutamylcysteine synthetase but not that of SOD2. As a consequence, autocrine hGH increased the antioxidant capacity of mammary carcinoma cells and protected against oxidative stress-induced apoptosis. Catalase activity was increased by autocrine production of hGH in mammary carcinoma cells and a catalase inhibitor abrogated protection from oxidative stress afforded by autocrine hGH. Autocrine hGH transcriptionally regulated catalase gene expression in a p44/42 MAP kinase-dependent manner and inhibition of MEK concordantly abrogated the protective effect of autocrine hGH against oxidative stress-induced apoptosis. Given that increased cellular oxidative stress is a key effector mechanism of specific chemotherapeutic agents, we propose that antagonism of autocrine hGH will improve the efficacy of chemotherapeutic regimes utilized for human mammary carcinoma.
Introduction
The hGH gene is expressed in epithelial cells of the normal human mammary gland (Raccurt et al., 2002) . Increased epithelial expression of the hGH gene is associated with the acquisition of pathological proliferation, and the highest level of hGH gene expression is observed in metastatic mammary carcinoma cells (Raccurt et al., 2002) . hGH receptor gene expression per mammary epithelial cell remains constant throughout the process of neoplastic progression (Mertani et al., 1998) , and therefore, alterations in the local concentration of ligand are likely to be pivotal in determining the effects of hGH on mammary epithelial cell behavior. We have demonstrated that autocrine production of hGH in immortalized human mammary epithelial cells concomitantly enhances proliferation and offers protection from apoptosis, forming the basis for abnormal mammary acinar morphogenesis, oncogenic transformation and tumor formation in vivo (Zhu et al., 2005) . Thus, simple forced expression the hGH gene is sufficient for oncogenic transformation of the immortalized human mammary epithelial cell. Furthermore, autocrine production of hGH, in mammary carcinoma cells with epithelial morphology, promotes mesenchymal cellular morphology, increased cell migration and increased metalloprotease (MMP) activity with subsequent acquisition of invasive behavior both in vitro and in vivo (Mukhina et al., 2004) . In stark contrast to the oncogenic and metastatic potential of autocrine hGH, exogenous hGH neither supports tumor formation nor invasion by human mammary epithelial cells.
Oxygen homeostasis is of critical importance for all mammalian cells. Oxygen radicals are continuously generated within mammalian cells as a consequence of the use of oxygen in aerobic respiration (Fridovich, 1978) . Superoxide anions are generated within the mitochondria and are sequentially reduced to hydrogen peroxide (H 2 O 2 ) and hydroxyl radicals. Disruption of the delicate balance between pro-oxidants and antioxidants has been implicated in the pathophysiology of many diseases (Mates et al., 1999) , such as autoimmune and neurodegenerative diseases, genetic and metabolic disorders and cancer. Increased expression of antioxidant enzymes has been documented in a wide variety of malignant tumors including mammary carcinoma (di Ilio et al., 1985; Iscan et al., 2002) and higher expression of antioxidant enzymes has been demonstrated to be associated with large, poorly differentiated mammary tumors (Thomas et al., 1997) . Recent studies have demonstrated that specific therapeutic effects also result from increased cellular oxidative levels and therefore oxidative stress has emerged as a key effector of cell death (Wen et al., 2002) . However, the cellular oxidative capacity is increased in advanced tumors and consequently cell death signaling is suppressed. As such, differences in the level of antioxidant enzymes in tumors may underlie the difference in responsiveness to chemotherapy (Akman et al., 1990) . The primary antioxidant enzymes are catalase, superoxide dismutase (SOD), glutathione peroxidase (GPX) and glutamylcystein synthetase (GCS) (El Mouatassim et al., 2000) . Catalase is the most potent enzyme regulating oxidative stress levels by conversion of H 2 O 2 to H 2 O and O 2 in peroxisomes. Catalase has been reported to be highly expressed in tumor tissues compared with normal tissues (Ripple et al., 1997) and its expression level is correlated with mammary tumor malignant grade and related death (Thomas et al., 1997) . However, the mechanisms responsible for the regulation of catalase are largely unknown. Analysis of the regulation of antioxidant enzymes, by which malignant carcinoma cells are conferred protection from oxidative stress, is vital for the understanding of cancer responsiveness to radio-or chemotherapies and the development of novel therapeutic approaches.
Herein, we have determined the effect of autocrine hGH on the expression of the major antioxidant enzymes, especially catalase, in mammary carcinoma cells. We demonstrated that autocrine production of hGH transcriptionally upregulates catalase mRNA and protein levels, with a subsequent increase in catalase activity; resulting in dramatic protection against oxidative stress-induced cell death. Finally, we demonstrate this protective effect of autocrine hGH, mediated via upregulation of catalase expression, is p44/42 MAP kinase dependent. Thus, p44/42 MAP kinase mediated transcriptional upregulation of catalase is one mechanism by which autocrine hGH promotes mammary carcinoma cell survival.
Results

Autocrine hGH protects mammary carcinoma cells from oxidative stress-induced apoptosis
We have previously demonstrated that autocrine production of hGH affords dramatic protection from apoptosis as a consequence of serum withdrawal (Kaulsay et al., 2001) . To determine if autocrine hGH protected from apoptosis induced by oxidative stress, MCF-MUT and MCF-hGH cells were exposed to differing concentrations of H 2 O 2 and cell number determined. Autocrine production of hGH increased mammary carcinoma cell survival in the presence of H 2 O 2 (Figure 1a) . The protective effect of autocrine hGH against H 2 O 2 -induced cell loss was observed over a wide dose range of H 2 O 2 (100-5000 mM). We next verified that the protective effect of autocrine hGH was due to protection from apoptosis. As shown in Figure 1b , apoptotic cell death in response to H 2 O 2 was reduced by autocrine hGH. Thus, autocrine hGH protects mammary carcinoma cells from H 2 O 2 -induced apoptotic cell death. We have previously demonstrated that exogenous administration of hGH to mammary carcinoma cells did not protect cells from apoptotic cell death (Kaulsay et al., 2001) . We therefore examined whether exogenous hGH would offer protection from oxidative stress-induced apoptosis. Exogenous hGH offered marginal protection from H 2 O 2 -induced cell death in MCF-MUT cells and offered no further survival advantage to MCF-hGH cells (Figure 1c ). To determine if autocrine hGH could protect mammary carcinoma cells not only from H 2 O 2 but also from other oxidative stress inducers, daunorubicin, 2,2 0 -Azobis-(2-amidinopropane) dihydrochloride (AAPH) and glutamate were employed. Daunorubicin, as an anthracycline chemotherapeutic agent, has been demonstrated to promote cell death via generation of reactive oxygen species (ROS) (Doroshow and Davies, 1986) . Glutamate disrupts the redox homeostasis of the cell resulting in the production of free radicals (Murphy et al., 1989; Choi, 1992) . AAPH a water-soluble radical initiator results in the formation of a peroxyle radical molecule (Terao and Niki, 1986) . As is observed in Figure 1d , autocrine hGH production by mammary carcinoma cells also resulted in increased survival against oxidative stress induced by daunorubicin, AAPH and glutamate. Thus, autocrine hGH protects human mammary carcinoma cells from oxidative stress-induced apoptosis.
Effect of autocrine hGH on antioxidant capacity in mammary carcinoma cells
Autocrine hGH protection from oxidative stress-induced apoptosis was suggestive that autocrine hGH increased the antioxidant capacity of the cell. Antioxidant concentrations were measured. The assay is based on the ability of antioxidants in the cells to inhibit oxidation of 2,2 0 azino-bis-[3-ethylbenz-thiazoline-6-sulfonic acid] (ABTS) to ABTS þ by metmyoglobin. MCF-hGH cells exhibited a significantly higher antioxidant capacity compared to MCF-MUT cells, whereas addition of 50 nM exogenous hGH had no significant effect on the total antioxidant capacity in either MCF-MUT or MCF-hGH cells (Figure 2 ). Autocrine hGH therefore increased the antioxidant capacity of the cell.
Autocrine hGH regulates the level of antioxidant enzymes in mammary carcinoma cells Differences in expression levels of specific antioxidant enzymes contributes to the total antioxidant status and survival of cells exposed to oxidative stress (St Clair et al., 1991; Wispe et al., 1992) . To determine if the observed autocrine hGH stimulated increase in antioxidant status was a result of altered expression of antioxidant enzymes, we examined the effect of autocrine hGH on the level of catalase, SOD1, SOD2, GPX and GCS. As the major mechanism by which GH affects cellular function is by regulation of the level of specific mRNA species (Isaksson et al., 1985) , we first resorted to RT-PCR to examine the effect of autocrine hGH on the mRNA level of the above enzymes. The level of SOD2 did not differ between MCF-MUT and MCF-hGH cells under serum-free conditions nor with stimulation by 50 nM exogenous hGH (Figure 3a ). However, the mRNA level of catalase, SOD1 (Mertani et al., 2001) , GPX and GCS were increased in MCF-hGH cells compared with MCF-MUT cells. Exogenous hGH exerted no significant effect on the mRNA of the examined antioxidant enzymes in either MCF-MUT and MCF-hGH cells (Figure 3a) . We next examined the protein level of catalase, SOD1, SOD2, GPX and GCS in MCF-MUT and MCF-hGH cells by Western blot analysis. Consistent with our RT-PCR results, autocrine production of hGH in MCF-hGH cells resulted in an increased protein expression of catalase, SOD1, GPX and GCS protein as compared with MCF-MUT cells (Figure 3b ). Exogenous hGH exerted no effect on antioxidant enzyme protein expression in either cell line. The level of SOD2 protein remained unchanged in both cell lines. To verify equal loading of proteins, the membranes were stripped and reblotted to demonstrate equivalent levels of b-actin protein under the different experimental conditions (Figure 3b ).
Autocrine hGH increases catalase activity in mammary carcinoma cells
Catalase is the most potent enzyme against oxidative stress and it has been implicated previously to be involved in the protection against oxidative stressinduced cell death (Sandstrom and Buttke, 1993) . We therefore utilized a catalase activity assay to determine if the autocrine hGH stimulated increase in catalase mRNA and protein could alter catalase enzymatic activity. Catalase activity assays were performed and as observed in Figure 4 , autocrine hGH production in MCF-hGH cells stimulated catalase activity approached 400% of that observed in MCF-MUT cells ( Figure 4 ). Exogenous hGH (50 nM) did not affect catalase activity in MCF-MUT cells nor did it further increase catalase activity in MCF-hGH cells.
The catalase inhibitor, 3-AT, prevents the protective effect of autocrine hGH on oxidative stress-induced apoptosis
To determine if the protective effect of autocrine hGH on oxidative stress-induced apoptosis resulted from the observed increased level of catalase activity, we examined the ability of autocrine hGH to protect from H 2 O 2 -induced cell death in the presence of the catalase specific inhibitor, 3 amino-1,2,4-triazole (3-AT). As is observed in Figure 5 , pretreatment with the catalase inhibitor completely prevented the protective effect of autocrine hGH against H 2 O 2 -induced apoptosis in mammary carcinoma cells ( Figure 5 ). Thus, autocrine hGH protection against oxidative stress-induced apoptosis is catalase activity dependent.
Forced expression of catalase in mammary carcinoma cells protects from H 2 O 2 -induced apoptosis
As autocrine hGH stimulated protection from H 2 O 2 -induced apoptosis was catalase activity dependent, we reasoned that simple forced expression of catalase should offer protection from oxidative stress-induced apoptosis. We therefore proceeded to examine the effect of forced expression of catalase in mammary carcinoma cells on protection from H 2 O 2 -induced cell death. Transient transfection of a catalase expression vector Figure 3 Effect of autocrine hGH and exogenous hGH on antioxidant enzyme mRNA and protein level in mammary carcinoma cells. MCF-MUT and MCF-hGH cells were grown to 80% confluence in serum-free media or in serum-free media supplemented with 50 nM hGH for 24 h. Experiments were performed as described under 'Materials and methods'. The mRNA and protein level of catalase, superoxide dismutase 1 (SOD1), superoxide dismutase 2 (SOD2), glutamylcystein synthetase (GCS) and glutamate peroxidase (GPX) were measured by RT-PCR (a) and Western blot (b). b-actin was used as loading control Figure 4 The effect of autocrine hGH and exogenous hGH on the level of catalase activity in mammary carcinoma cells. MCF-MUT and MCF-hGH cells were grown to 80% confluence in serum-free media or in serum-free media supplemented with 50 nM hGH for 24 h. Catalase activity assays were performed as described under 'Materials and methods'. Results represent means7s.d. of triplicate determinations. *Po0.01
Figure 5 The catalase inhibitor 3 amino-1,2,4-triazole (3-AT), prevents autocrine hGH-dependent cell survival after oxidative stress. MCF-MUT and MCF-hGH cells were grown to 80% confluence in six-well plates. Cells were treated with 20 mM 3-AT in serum-free media for 1 h before treatment of 1000 mM H 2 O 2 . Cells were trypsinized and the cell number was determined using a hematocytometer. Results represent means7s.d. of triplicate determinations. *Po0.01 increased catalase protein level in both MCF-MUT cells and MCF-hGH cells ( Figure 6a ). As observed in Figure 6b , transient transfection of catalase offered protection against H 2 O 2 -induced apoptosis in MCF-MUT cells to a level similar to that observed in MCFhGH cells. Forced expression of catalase offered no further protection for MCF-hGH cells from oxidative stress indicative that the autocrine hGH stimulated increase in catalase activity already offered maximal catalase mediated protection from oxidative stress. Therefore, catalase is protective against oxidative stress-induced apoptosis in human mammary carcinoma cells.
Autocrine hGH increases activity from a reporter plasmid containing the promoter region of the catalase gene
We have demonstrated above that autocrine hGH increased the level of catalase mRNA as observed by RT-PCR analysis. In order to further delineate the mechanism of regulation of catalase by autocrine hGH, we utilized a luciferase reporter containing the 4526 bp promoter region upstream to the 5 0 start site of the catalase gene. Autocrine hGH production by MCFhGH cells increased luciferase activity from the catalase promoter when compared to MCF-MUT cells (Figure 7a ). Exogenous hGH (50 nM) did not alter catalase gene promoter activity in MCF-MUT cells nor did it further increase transcription of the catalase gene in MCF-hGH cells. To exclude the possibility that the Figure 6 Forced expression of catalase protects mammary carcinoma cells from oxidative stress. MCF-MUT and MCFhGH cells were grown to 80% confluence in six-well plates. 0.5 mg of the catalase expression vector (pCDNA3-catalase) or control vector (pCDNA3) per well were transfected in serum-free media for 12 h before the medium was changed to fresh serum-free media. Catalase protein level was determined by Western blot. b-Actin was used as loading control. (a) Cells were treated with 500 mM H 2 O 2 for 6 h before trypsinization and determination of cell number using a hematocytometer (b). Results represent means7s.d. of triplicate determinations. *Po0.01; **Po0.05 Figure 7 Effect of autocrine hGH and exogenous hGH on luciferase activity from a reporter plasmid containing the promoter region (4526 bp) of the catalase gene. (a) MCF-MUT and MCFhGH cells in serum-free media or in serum-free media supplemented with 50 nM hGH were transiently transfected with 0.1 mg of catalase promoter reporter plasmid and luciferase assays were performed as described under 'Materials and methods'. (b) MCF-7 cells in serum-free media or in serum-free media supplemented with 50 nM hGH were transiently transfected with the respective plasmids (0.1 mg for catalase reporter plasmid and additionally either 0.5 mg of pMT-MUT or pMT-hGH), and luciferase assays were performed as described under 'Materials and methods'. The luciferase activities were normalized on the basis of protein contents as well as on the b-galactosidase activity of pCMV-bgalactosidase vector. Values are depicted as means7s.d. from three independent experiments. *Po0.01 (Mize et al., 2003) . p44/42 MAP kinase is also utilized by hGH (Campbell et al., 1992) to exert pleiotropic cellular effects . We therefore proceeded to examine the effect of autocrine hGH production in mammary carcinoma cells on p44/42 MAP kinase activity. We first determined p44/42 MAP kinase activity in MCF-MUT and MCF-hGH cells. Autocrine hGH in mammary carcinoma cells resulted in a significant increase of p44/42 MAP kinase activity as evidenced by in vitro kinase activity ( Figure 8a ). We also employed a selective inhibitor of the p44/42 MAP kinase pathway, PD098059, which prevents activation of the MAP kinase kinase MEK1 (Alessi et al., 1995; Dudley et al., 1995) . 50 mM PD098059 prevented the autocrine hGH stimulated increase in p44/42 MAP kinase activity (Figure 8a ). For control purposes, we utilized the same total cell lysates subjected to the p44/42 MAP kinase activity assay to determine total p44/42 MAP kinase and b-actin protein as loading control (Figure 8a ). It has been demonstrated that Elk-1-mediated transcription stimulated by GH is entirely mediated by p44/42 MAP kinase (Hodge et al., 1998; Zhu and Lobie, 2000) . We therefore examined the effect of autocrine hGH production in mammary carcinoma cells on Elk-1-mediated transcription. Autocrine hGH resulted in increased Elk-1-mediated transcription and PD098059 completely prevented this autocrine hGH-stimulated Elk-1-mediated transcription (Figure 8b) . Therefore, autocrine hGH production in mammary carcinoma cells resulted in activation of p44/ 42 MAP kinase and subsequent Elk-1-mediated transcription.
Autocrine hGH regulation of catalase gene transcription is p44/42 MAP kinase dependent
We next examined if catalase gene transcription is regulated by autocrine hGH in a p44/42 MAP kinasedependent manner. Semiquantitative RT-PCR, reporter assay for catalase promoter activity and Western blot analysis were utilized to analyse the effect of PD098059 on the regulation of catalase by autocrine hGH. The increase in catalase mRNA level observed in MCF-hGH (Figure 9a ). Concordantly, catalase promoter analysis also demonstrated that treatment with PD098059 (50 mM) completely abrogated autocrine hGH stimulation of catalase gene transcription (Figure 9b) . Furthermore, catalase promoter analysis demonstrated that PD098059 diminished autocrine hGH stimulation of the catalase promoter in a dosedependent manner (Figure 9b ). The increase in catalase protein level stimulated by autocrine hGH was also prevented by PD098059 (Figure 9c ). Thus, autocrine hGH regulation of catalase gene transcription is entirely dependent on p44/42 MAP kinase activity.
Autocrine hGH protection from oxidative stress-induced apoptosis is p44/42 MAP kinase dependent p44/42 MAP kinase-dependent transcriptional regulation of catalase gene transcription by autocrine hGH is indicative that autocrine hGH protection from oxidative stress-induced apoptosis will require p44/42 MAP kinase activity. MCF-MUT and MCF-hGH cells were therefore treated with 50 mM PD098059 and cell survival determined after application of oxidative stress. Treatment of MCF-hGH cells with PD098059 completely prevented the ability of autocrine hGH to protect cells from oxidative stress-induced apoptosis (Figure 10 ). To verify that loss of protection from oxidative stressinduced apoptosis upon inhibition of p44/42 MAP kinase was specifically due to loss of catalase transcription, we therefore performed a rescue experiment. Forced expression of catalase restored protection from oxidative stress-induced apoptosis consequent to inhibition of p44/42 MAP kinase (Figure 10 ). Thus, the protective effect of autocrine hGH against oxidative stress-induced cell death in mammary carcinoma cells is mediated by stimulation of catalase gene transcription via the p44/42 MAP kinase pathway.
Discussion
We have demonstrated herein that autocrine production of hGH by human mammary carcinoma cells confers Figure 9 Autocrine hGH regululation of catalase gene transcription is p44/42 MAP kinase dependent. MCF-MUT and MCF-hGH cells were grown to 80% confluence and serum deprived for 24 h. (a) Cells were treated with PD098059 and processed for RT-PCR as described in 'Materials and methods'. b-Actin was used as loading control. (b) Cells were treated with PD098059 after transfection of catalase promoter reporter construct and processed for luciferase assay as described in 'Materials and methods'. The luciferase activities were normalized on the basis of protein contents as well as on the b-galactosidase activity of pCMV-bgalactosidase vector. The data are presented as the mean7s.d. of triplicate determinations. *Po0.01; **Po0.05. (c) Cells were treated with PD098059 or exogenous hGH and processed for Western blot as described in 'Materials and methods'. b-Actin was used as loading control Figure 10 Autocrine hGH protection of mammary carcinoma cells from oxidative stress-induced apoptosis requires p44/42 MAP kinase-dependent transcription of catalase. MCF-MUT and MCFhGH cells were grown to 80% confluence and serum deprived for 24 h. Cells were treated with 50 mM PD098059 with or without transfection of catalase expression vector for 12 h before 100 mM H 2 O 2 was added into the media for 30 h. Cells were trypsinized and the cell number was determined using a hematocytometer. The data are presented as the mean7s. (Yokomizo et al., 1995; Takahashi et al., 2002) . Their activity is to a degree dependent on the induction of tumor cell apoptosis in response to oxidative stress and oxygen radical-induced DNA damage (Yokomizo et al., 1995) . Studies in a variety of cell types suggest that chemotherapeutic agents induce tumor cell apoptosis in part by increasing formation of ROS (Siitonen et al., 1999) . Oxygen dependency has been documented for a number of chemotherapeutic agents (e.g. cyclophosphamide, carboplatin, and doxorubicin) under in vitro and in vivo conditions (Teicher et al., 1990) . Furthermore, several drug-resistant tumor cell lines have been shown previously to contain higher levels of antioxidant enzymes than the parental drug-sensitive counterpart (Godwin et al., 1992) . Given that cellular oxidative stress has emerged as a key effector mechanism for specific therapeutic approaches used in the treatment of mammary carcinoma (Yokomizo et al., 1995) , such potential avenues targeting autocrine hGH would presumably increase clinical efficacy. Indeed, we have demonstrated herein that autocrine hGH protects from daunorubicin-induced cell death and additionally have preliminary evidence that autocrine hGH produces resistance to cyclophosphamide-induced apoptosis in vitro (Zhu Z, Lee KO, Lobie PE, unpublished) . In mammalian cells, biological systems have evolved an array of antioxidant defense mechanisms to combat the effects of ROS. Catalase and SOD, which has two isoforms SOD1 and SOD2, in conjunction with GPX and GCS play key roles in the detoxification of superoxide anion and H 2 O 2 , defence against free radicals, peroxides and a wide range of xenobiotics and carcinogens (Mates et al., 1999) . In addition to catalase, we observed here that autocrine hGH also increased the expression of SOD1, GPX and GCS. We had previously demonstrated that autocrine hGH increased expression of SOD1 mRNA by microarray analysis (Mertani et al., 2001) . Autocrine hGH regulation of these enzymes would also presumably contribute to the autocrine hGH increase in antioxidant capacity within the cell and consequently to protection from oxidative stress-induced apoptosis. SOD1, GPX and GCS have also previously been implicated in the pathophysiology of mammary carcinoma. Increased SOD mRNA expression has been observed in tumor tissues from patients with carcinoma of the mammary gland (Li et al., 1998) and associated with increased resistance to chemotherapeutic agents (Zyad et al., 1994) . Increased GCS activity, the rate-limiting enzyme for the synthesis of glutathione (GSH), has been shown to be associated with the increased intracellular glutathione levels seen in many drug-resistant cancer cell lines (Yao et al., 1995) . Forced expression of GCS also confers resistance to chemotherapeutic agents (Tipnis et al., 1999) . A significant increase in the activity of GPX, one of the first step enzymes in defense against H 2 O 2 and other hydroperoxides, has been reported in breast cancer (Zachara et al., 1993) . Increased expression of GPX also promotes resistance of cancer cells against chemotherapeutic drugs (Yang et al., 1997) . Furthermore, GPX plays a key role in tumorigenesis by altering the lipoxygenase and cyclooxygenase pathways (Bryant et al., 1982; Capdevila et al., 1995) . Thus, autocrine hGH not only selectively regulates catalase activity but also integrates the cellular response to oxidative stress, by regulation of pivotal enzymes involved in oxidant protection.
Catalase is a cytoplasmic enzyme that catalyses the reduction of H 2 O 2 to H 2 O and O 2 , thereby preventing the accumulation of H 2 O 2 and the toxic consequences of intereaction of H 2 O 2 with other cellular components (Chelikani et al., 2004) . We have demonstrated herein that autocrine production of hGH in mammary carcinoma cells results in a transcriptional upregulation of catalase gene expression. This increase in catalase gene transcription results into higher cellular levels of catalase protein with consequent catalase-mediated protection from oxidative stress-induced apoptosis. In support of these observations, catalase has previously been implicated in the control of cell survival since its forced expression in different cell types results in protection from apoptosis (Santanam et al., 1999; Tome et al., 2003) . Concordantly, endothelial cells and smooth muscle cells have very low levels of catalase activity, and therefore are more susceptible to damage by H 2 O 2 (Shingu et al., 1985) . It has been reported that catalase activity in mammary carcinoma is markedly elevated compared to adjacent normal tissue (Kumaraguruparan et al., 2002) and it is likely that autocrine hGH produced by mammary carcinoma cells (Raccurt et al., 2002) contributes to this differential expression. Several groups have explored the transcriptional regulation of the catalase gene. Transcriptional activity of the 5 0 -flanking region of the rat catalase gene has been studied in transfected cells and in transgenic mice (Van Remmen et al., 1998) . The results demonstrated that the expression of the catalase gene is tissue-specific. This may also be the case for GH regulation of catalase as GH has previously been demonstrated to decrease catalase activity in kidney and heart . In contrast, the liver of male GH receptor null mice display lower catalase activity (Hauck et al., 2002) , whereas kidney from GH transgenic mice exhibits reduced catalase activity (Brown-Borg and Rakoczy, 2000) . Confoundingly, GH deficient dwarf mice have increased hepatic catalase activity (Brown-Borg et al., 1999) despite increased sensitivity to oxidative stressinduced apoptosis (Kennedy et al., 2003) . Thus, endocrine GH regulation of catalase appears to be complex and tissue specific. It should also be considered that autocrine hGH differentially regulates gene expression in comparison to exogenous hGH (Mertani et al., 2001; Graichen et al., 2002; Xu et al., 2005, in press) , and this also appears to be the case for catalase. Autocrine hGH regulated genes therefore need not be concordantly regulated by the exogenous hormone. In any case, we have demonstrated here that autocrine hGH specifically increases catalase activity in human mammary carcinoma cells.
We observed that autocrine hGH regulated transcription of the catalase gene in a p44/42 MAP kinasedependent manner. Indeed, inhibition of p44/42 MAP kinase also prevented the protection from oxidative stress-induced apoptosis afforded by autocrine hGH; an effect that could subsequently be rescued by forced expression of catalase. The importance of the p44/42 MAP kinase pathway in oxidative stress responses has clearly been demonstrated in both in vivo and in vitro systems. In 1996, Guyton et al. (1996) implicated p44/42 MAP kinase activation as a survival stimulus following oxidant injury. Subsequent studies from a number of laboratories confirmed these findings in other cell types and with other oxidative stress agents (Wang et al., 1998; Ikeyama et al., 2002) . WT1/Egr has been demonstrated to regulate human catalase gene expression in H 2 O 2 -resistant HL60 cells (Nenoi et al., 2001) . Among the transcription factor motifs found in the catalase promoter are tandemly repeated Egr-1 recognition sequences (14). In this regard, it is interesting that GH has been demonstrated to regulate Egr-1 transcription (Hodge et al., 1998; Clarkson et al., 1999) by use of the p44/42 MAP kinase regulated Elk-1 (Clarkson et al., 1999; Zhu and Lobie, 2000) . Autocrine hGH regulation of the catalase promoter may therefore represent a secondary transcriptional event in response to autocrine hGH activation of p44/42 MAP kinase (i.e. p44/42MAP kinase activates Elk-1-mediated transcription of Egr-1 required for transcriptional activation of the catalase promoter). Further analysis of the catalase promoter should allow for precise delineation of the mechanism of transcriptional activation by autocrine hGH.
It is interesting that autocrine hGH utilizes p44/42 MAP kinase to regulate catalase promoter activity, yet exogenous hGH, which also activates p44/42 MAP kinase in MCF-7 cells (Liu and Lobie, in preparation), does not increase transcription of the catalase gene. One explanation may be the observed transient activation of p44/42 MAP kinase by exogenous hGH in comparison to the sustained activation of p44/42 MAP kinase activity by autocrine hGH. We have observed that exogenous hGH transiently increases p44/42 MAP kinase activity for 5-10 min despite producing a similar fold increase in activity (Liu and Lobie, in preparation) compared to autocrine hGH (reported herein). Under the experimental conditions utilized herein, we have observed that autocrine hGH maintains activation of p44/42 MAP kinase for at least 48 h. It has been previously reported that sustained activation of p44/42 MAP kinase is required for activation of Elk-1-mediated transcription (York et al., 1998; Zhu et al., 2002) and we observe no stimulation of Elk-1 mediated transcription by exogenous hGH (Liu and Lobie, unpublished) in contrast to robust activation of Elk-1-mediated transcription by autocrine hGH. Such discrepancy in the activation of Elk-1 mediated transcription by autocrine and exogenous hGH would preclude an exogenous hGH increase in catalase promoter activity. Such differences in the temporal activation of p44/42 MAP kinase and other signaling molecules utilized by hGH could potentially underlie the functional discrepancies previously observed between autocrine and exogenous hGH in human mammary carcinoma cells (Kaulsay et al., 2000 (Kaulsay et al., , 2001 Mertani et al., 2001; Graichen et al., 2002; Zhang et al., 2003; Mukhina et al., 2004; Zhu et al., 2005) .
In conclusion, we have demonstrated here that autocrine production of hGH by mammary carcinoma cells results in a specific increase in catalase gene transcription in a p44/42 MAPK-dependent manner with consequent increase in catalase protein and activity, and subsequent protection from oxidative stress-induced apoptosis. Thus, one mechanism by which autocrine hGH promotes mammary carcinoma cell survival is by transcriptional upregulation of catalase. Such a mechanism is analogous and complementary to the ability of hGH to activate transcriptionally protein effector molecules that stimulate cell cycle progression and cell survival (Le Roith et al., 2001 ).
Materials and methods
Materials
Recombinant human growth hormone (hGH) was a generous gift of Novo Nordisk (Singapore). Secondary anti-IgG antibodies and the enhanced chemiluminescence (ECL) kit were purchased from Amersham Pharmacia Biotech (Buckinghamshire, UK). The p44/42 MAP kinase assay kit was purchased from New England Biolabs (Beverly, MA, USA). PD098059, 3-amino-1,2,4-triazole, daunorubicin, catalase assay kit and total antioxidant status kit were purchased from Calbiochem (Darmstadt, Germany). The transfection reagent Effectene was purchased from Qiagen (Hilden, Germany). Complete protease inhibitor cocktail tablets were purchased from Roche Diagnostics (Mannheim, Germany). Glutamate and Azobis were obtained from SigmaChemical (St Louis, MO, USA). The following antibodies were purchased: Rabbit p44/42 MAP kinase antibody from New England Biolabs (Beverly, MA, USA), sheep Cu/ZnSOD antibody from Upstate (Lake Placid, NY, USA), polyclonal gamma GCS antibody from NeoMarkers (Fremont, CA, USA), monoclonal MnSOD and monoclonal b-Actin antibodies from Transduction Laboratories (Lexington, KY, USA), sheep GPX antibody from US Biological (Swampscott, MA, USA), polyclonal catalase antibody and anti-Sheep IgG from Calbiochem (Darmstadt, Germany).
Constructs
pCDNA3-catalase expression vector encoding the full-length of catalase gene was a generous gift of Dr Stephan Lortz (Hannover, Germany). The fusion trans-activator plasmid (pFA-Elk-1) consisting of the DNA binding domain of Gal4
(residues 1-147) and the transactivation domain of Elk-1 were purchased from Stratagene (La Jolla, CA, USA). pGL3-catalase promoter reporter construct containing 4.5 kb of catalase gene promoter was constructed as published (Nenoi et al., 2001) . All plasmids were prepared with the plasmid maxiprep kit from Qiagen.
Cell culture
The MCF-7 cell line was obtained from American Type Culture Collection (Manassas, VA, USA) and stably transfected with an expression plasmid containing the wild-type hGH gene (pMT-hGH) under the control of the metallothionein-1a promoter (designated MCF-hGH). For control purposes, the ATG start site in pMT-hGH was disabled via a mutation to TTG generated by standard techniques (pMT-MUT), and MCF-7 cells stably transfected with this plasmid were designated MCF-MUT. MCF-MUT cells therefore transcribe the hGH gene but do not translate the mRNA into protein. MCF-hGH cells synthesized hGH mRNA and hGH protein within the cell and secreted hGH into the extracellular medium. The concentration of hGH secreted into the medium by MCF-hGH cells under the experimental conditions described is in the range of 100 pM (Kaulsay et al., 1999) . A detailed description of the characterization of these cell lines has been published previously (Kaulsay et al., 1999) . MCF-MUT and MCF-hGH cells were cultured in RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum, 100 IU/ml penicillin, 100 mg/ml streptomycin and 2 mM L-glutamine. Fetal bovine serum was purchased from HyClone Laboratories (Logan, UT, USA), and all other cell culture materials were obtained from Sigma Chemical Co. (St Louis, MO, USA).
Total cell number assay
Cells (5 Â 10 4 ) were seeded into six-well plates in monolayers in serum-free media or in serum-free media supplemented with either 50 nM hGH. After the cells were treated with different pharmacological agents in serum-free media for the appropriate time, cells were trypsinized with 0.5% trypsin and the cell number was determined using a hematocytometer.
Apoptosis assay
Apoptotic cell death was measured by fluorescent microscopic analysis of cell DNA staining patterns with Hoechst 33258 from Sigma Chemical Co. (St Louis, MO, USA). Cells (5 Â 10 4 ) were seeded to glasscover slips in six-well plates in 10% FBS for 24 h before cells were treated with indicated doses of H 2 O 2 in serum-free media for appropriate time. Cells were fixed in 4% paraformaldehyde in PBS (pH 7.4) and stained with the karyophilic dye Hoechst 33258 (20 mg/ml) for 10 min at room temperature. Following washing with PBS, nuclear morphology was examined under a UV-visible fluorescence microscope (Zeiss Axioplan). Apoptotic cells were distinguished from viable cells by their nuclear morphology characterized by nuclear condensation and fragmentation as well as the higher intensity of the blue fluorescence of the nuclei. For statistical analysis, three times 300 cells were counted in eight random microscopic fields at Â 400 magnification.
Reverse transcriptase-PCR
MCF-MUT and MCF-hGH cells were grown to 80% confluence in serum-free media or in serum-free media supplemented with 50 nM hGH for 24 h, and total RNA was extracted and RT-PCR was performed. To compare the PCR products semiquantitatively, RT-PCR was carried out with 1 mg total RNA by 941C for 15 s, an annealing step at 551C for 30 s and an extension step at 721C for 1 min for indicated cycles (catalase: 30 cycles; SOD1: 30 cycles; SOD2: 30 cycles; GPX: 30 cycles; GCS: 30 cycles; b-actin: 22 cycles) and the amplified b-actin cDNA served as an internal control for cDNA quantity and quality. All RNA samples were treated with DNaseI to avoid genomic DNA contamination.
The sequences of the oligonucleotide primers used for RT-PCR are as follows:
Western blot analysis
MCF-MUT and MCF-hGH cells were grown to 80% confluence in serum-free media or in serum-free media supplemented with 50 nM hGH or with 50 mM PD098095 for 24 h. Whole-cell lysates was prepared according to the protocol described (Mertani et al., 2001) . Proteins were resolved by SDS-polyacrylamide (12%) gel electrophoresis, transferred onto a nitrocellulose membrane, and blotted with the antibodies as indicated. For reblotting, membranes were stripped at 501C for 30 min in the solution containing 62.5 mM Tris-HCl, pH 6.7, 2% SDS and 0.7% mercaptoethanol. Blots were then washed for 30 min with several changes of PBST at 221C. Efficacy of stripping was determined by reexposure of the membranes to ECL. Thereafter, membranes were reblocked and immunolabeled as described above.
Luciferase reporter assay for catalase promoter
Cells were cultured to 40-60% confluence in six-well plates. Transient transfection was performed by use of Effectene as described (Mertani et al., 2001) . The catalase promoter-luciferase construct was described previously (Nenoi et al., 2001) . Briefly, 0.1 mg of the catalase promoter construct (and other expression constructs or pharmacological agents as appropriate) were transfected per well in serum-free RPMI medium for 12 h before the medium was changed to fresh serum-free RPMI with or without 50 nM hGH. After a further 24 h, cells were washed with PBS, and luciferase assays were performed as previously described (Wood et al., 1995) . Results were normalized to the level of b-galactosidase activity and protein concentration in the samples.
Elk-1 reporter assay
Cells were cultured to 60-80% confluence in six-well plates and transfected with 0.4 mg of the reporter plasmid pFR-Luc, 8 ng of the fusion trans-activator plasmid pFA-Elk1 and 1 mg of the expression plasmid as indicated or empty vector in each well. Cells were transfected in serum-free RPMI medium for 8 h before the medium was changed to fresh serum-free RPMI for 24 h. The cells were washed in cold phosphate-buffered saline twice and then lysed with 150 ml of 1 Â lysis buffer (25 mM Tris-phosphate, pH 7.8, 2 mM EDTA, 2 mM EDTA, 2 mM dithiothreitol, 10% glycerol, 1% Triton X-100) for 20 min, and supernatant was collected by centrifugation at 14 000 g for 15 min. The luciferase activity was detected and normalized by protein content.
Catalase activity assay and total antioxidant status assay MCF-MUT and MCF-hGH cells were grown to 80% confluence in serum-free media or in serum-free media supplemented with 50 nM hGH for 24 h. Cells were washed with cold PBS for two times and scraped with rubber scrapers in appropriate amount of PBS. Cells were homogenized with syringes. Protein concentration was measured and equal amount of protein was subjected to catalase activity assay and total antioxidant status assay. Catalase activity and total antioxidant status was measured by using the Catalase Assay kit and Total Antioxidant Status kit according to the manufacturer's instructions.
p44/42 MAP kinase assay
MCF-MUT and MCF-hGH cells were grown to 80% confluence in serum-free media or in serum-free media supplemented with 50 mM PD098095 for 24 h. p44/42 MAPK kinase assays were performed according to the manufacturer's instructions. Briefly, cells were lysed at 41C in lysis buffer provided and the cell extract containing 200 mg of protein per sample was incubated overnight with 15 ml immobilized phospho-specific p44/42 MAP kinase (Tyr202/Tyr204) monoclonal antibody, which recognizes only the active form of p44/ 42 MAP kinase. The pellets were washed twice with 500 ml of lysis buffer and twice with 500 ml of kinase assay buffer provided. The kinase reactions were performed in the presence of 2 mg of Elk-1 fusion protein and 200 mM ATP at 301C for 30 min. Elk-1 phosphorylation was detected by use of a specific phospho-Elk-1 (Ser383) antibody. For control purposes, we utilized the same total cell lysates subjected to the p44/42 MAP kinase activity assay to determine the total cellular p44/42 MAP kinase and b-actin protein as loading control.
Statistics
All experiments were repeated at least three to five times. All numerical data are expressed as mean7s.d. Data were analysed using the two-tailed t-test or analysis of variance.
